08921143 · Active · incorporated 12 years, 4 months ago · Cambridge
Biotech Biotech & Life Sciences Drug Discovery Series B+
A cell engineering company focused on commercializing gene editing and gene modulation applications in life sciences research.
See the complete cap table with every shareholder, founder tags, dilution across 26 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.